Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 721 AL 735

Mitochondrially-Targeted Therapeutic Strategies for Alzheimer's Disease

Onyango IG, Bennett JP, Stokin GB.

Curr Alzheimer Res. 2021;18(10):753-771. doi: 10.2174/1567205018666211208125855.

Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data

Li Z, Jiang X, Wang Y, Kim Y.

Emerg Top Life Sci. 2021 Dec 21;5(6):765-777. doi: 10.1042/ETLS20210249.

Magnetic Resonance Imaging in Animal Models of Alzheimer's Disease Amyloidosis

Ni R.

Int J Mol Sci. 2021 Nov 25;22(23):12768. doi: 10.3390/ijms222312768.

Role of Receptors in Relation to Plaques and Tangles in Alzheimer's Disease Pathology

Sharma K, Pradhan S, Duffy LK, Yeasmin S, Bhattarai N, Schulte MK.

Int J Mol Sci. 2021 Nov 30;22(23):12987. doi: 10.3390/ijms222312987.

A Review of the Current Mammalian Models of Alzheimer's Disease and Challenges That Need to Be Overcome

Mckean NE, Handley RR, Snell RG.

Int J Mol Sci. 2021 Dec 6;22(23):13168. doi: 10.3390/ijms222313168.

What have we learned from past failures of investigational drugs for Alzheimer's disease?

Imbimbo BP, Watling M.

Expert Opin Investig Drugs. 2021 Dec;30(12):1175-1182. doi: 10.1080/13543784.2021.2017881. Epub 2021 Dec 20.

The engagement of microglia in tau-targeted immunotherapy in Alzheimer's disease

Palova D, Turic Csokova N, Markova K, Kontsekova E, Kovacech B, Zilkova M.

Gen Physiol Biophys. 2021 Nov;40(6):463-478. doi: 10.4149/gpb_2021029.

Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction

Moss DE, Perez RG.

Curr Alzheimer Res. 2021;18(13):1010-1022. doi: 10.2174/1567205018666211215150547.

Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia

Mühlbauer V, Möhler R, Dichter MN, Zuidema SU, Köpke S, Luijendijk HJ.

Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2.

Remote activity monitoring for family caregivers of persons living with dementia: a mixed methods, randomized controlled evaluation

Gaugler JE, Zmora R, Mitchell LL, Finlay J, Rosebush CE, Nkimbeng M, Baker ZG, Albers EA, Peterson CM.

BMC Geriatr. 2021 Dec 18;21(1):715. doi: 10.1186/s12877-021-02634-8.

TDP-43 Pathology in Alzheimer's Disease

Meneses A, Koga S, O'Leary J, Dickson DW, Bu G, Zhao N.

Mol Neurodegener. 2021 Dec 20;16(1):84. doi: 10.1186/s13024-021-00503-x.

Co-Expression Network Analysis of Micro-RNAs and Proteins in the Alzheimer's Brain: A Systematic Review of Studies in the Last 10 Years

Tasker R, Rowlands J, Ahmed Z, Di Pietro V.

Cells. 2021 Dec 9;10(12):3479. doi: 10.3390/cells10123479.

Advances in Genetics and Epigenetic Alterations in Alzheimer's Disease: A Notion for Therapeutic Treatment

Rabaneda-Bueno R, Mena-Montes B, Torres-Castro S, Torres-Carrillo N, Torres-Carrillo NM.

Genes (Basel). 2021 Dec 8;12(12):1959. doi: 10.3390/genes12121959.

Genetic Insights into the Impact of Complement in Alzheimer's Disease

Torvell M, Carpanini SM, Daskoulidou N, Byrne RAJ, Sims R, Morgan BP.

Genes (Basel). 2021 Dec 15;12(12):1990. doi: 10.3390/genes12121990.

Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer's Disease and Related Dementias

Nguyen LD, Chau RK, Krichevsky AM.

Genes (Basel). 2021 Dec 17;12(12):2005. doi: 10.3390/genes12122005.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias